Who is sponsoring NCT05015751?

NCT05015751 is sponsored by Rhaeos, Inc..

What drugs are being tested in NCT05015751?

Interventions in NCT05015751: Thermal Anisotropy Measurement Device.

What condition does NCT05015751 study?

NCT05015751 studies Hydrocephalus.

Is NCT05015751 still recruiting?

NCT05015751 is currently completed. Last updated 19 December 2024.

Are results published for NCT05015751?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-12-19 · How we verify

NCT05015751

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of CSF Shunt Flow With Thermal Measurements A

Completed Results posted Last updated 19 December 2024

What this trial tests

trial testing Thermal Anisotropy Measurement Device in Hydrocephalus in 44 participants. Completed in 13 July 2022.

Timeline

25 August 2021

Primary endpoint
13 July 2022

13 July 2022

Quick facts

Lead sponsor	Rhaeos, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	44
Start date	25 August 2021
Primary completion	13 July 2022
Estimated completion	13 July 2022
Sites	4 locations across United States

Drugs / interventions tested

Thermal Anisotropy Measurement Device

Conditions studied

Hydrocephalus — all drugs for Hydrocephalus →

Sponsor

Rhaeos, Inc. — full company profile →

Who can join

Eligibility, any sex, with Hydrocephalus. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Study Device Sensitivity Primary · 14-day follow-up period

Study device sensitivity is calculated as TP / (TP + FN), where TP = true positive and FN = false negative.

Group	Value	95% CI
Hydrocephalus Patients	88

Study Device Specificity Primary · 14-day follow-up period

Study device specificity is calculated as TN / (TN + FP), where TN = true negative and FP = false positive.

Group	Value	95% CI
Hydrocephalus Patients	87

Sponsor's own description

This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Thermal Anisotropy Measurement Device

Trials testing the same drug.

NCT05432986 — Assessment of CSF Shunt Flow With Thermal Measurements B · completed

Other recruiting trials for Hydrocephalus

Currently open trials in the same condition.

NCT07478926 — Flow Detection in Open and Closed Shunt Valve Periods · NA · recruiting
NCT07442929 — Crystallization of LA and Adjuvant Mixtures in Cerebrospinal Fluid · recruiting
NCT06797219 — Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4 · NA · recruiting
NCT07380477 — VentricuLostomy AssoCiaTed InfeCtions (LACTIC): Focus on CSF Lactate and Sampling Site · recruiting
NCT06276543 — Bactiseal Catheter Safety Registry Study · recruiting

Other Rhaeos, Inc. trials

Trials by the same sponsor.

NCT07478926 — Flow Detection in Open and Closed Shunt Valve Periods · NA · recruiting
NCT06753929 — Assessment of CSF Shunt Flow in an Outpatient Setting with a Thermal Measurement Device · NA · completed
NCT06506045 — Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device · terminated
NCT06513572 — Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices · terminated
NCT06524492 — Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05015751 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rhaeos, Inc.
Last refreshed: 19 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05015751.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing